Objective: To investigate the roles and mechanisms of vitamins A and D in pregnant women with hypothyroidism. Methods: The study sample was collected from January 2024 to December 2025, consisting of 100 pregnant women with hypothyroidism, designated as the hypothyroidism group. Normal pregnant women undergoing prenatal check-ups at our hospital during the same period were selected as the normal group. Serum levels of vitamins A and D were measured in both groups, along with serum thyroid-stimulating hormone (TSH), free thyroxine (FT4), and free triiodothyronine (FT3) levels. Comparative analysis of relevant indicators between the two groups was conducted, and the correlations between vitamin A and D levels and thyroid function indicators were explored. Results: Compared with the normal group, the hypothyroidism group exhibited significantly lower serum levels of vitamins A and D, with statistically significant differences (P < 0.05). The TSH level in the hypothyroidism group was significantly higher, while FT4 and FT3 levels were significantly lower (P < 0.05). Correlation analysis revealed that serum vitamin A and D levels were significantly negatively correlated with TSH levels and significantly positively correlated with FT4 and FT3 levels (P < 0.05). Questionnaire results indicated that the proportion of inadequate vitamin A and D intake and insufficient sunlight exposure was higher in the hypothyroidism group than in the normal group. Conclusion: Pregnant women with hypothyroidism have reduced levels of vitamins A and D, and their deficiency may contribute to the development of hypothyroidism by affecting thyroid hormone synthesis and secretion as well as immune regulatory mechanisms. Strengthening the assessment and intervention of vitamin A and D nutrition in pregnant women can help improve thyroid function status.
Wang J, 2025, Evaluation of the Safety and Efficacy of Vitamin D Supplementation Therapy in Pregnant Women with Hypothyroidism. Primary Medical Forum, 29(20): 68–71.
Ye X, Mao G, 2025, Expression and Significance of Thyroid-Stimulating Hormone, 25-Hydroxyvitamin D, and Fibroblast Growth Factor-21 in Subclinical Hypothyroidism during Pregnancy. Maternal and Child Health Care of China, 40(9): 1576–1579.
Tang C, Zhang G, Shu Y, et al., 2025, Expression and Clinical Significance of Serum 25-Hydroxyvitamin D in Early Pregnancy in Pregnant Women with Hypothyroidism. Guide of China Medicine, 23(21): 15–18.
Zhou H, Ding Y, 2024, Research Progress on the Levels of 25-Hydroxyvitamin D and Thyroid-Stimulating Hormone Receptor Antibodies in Pregnant Women with Hypothyroidism. Maternal and Child Health Care of China, 39(2): 385–387 + F0004.
Xu S, Wang M, Zhang X, et al., 2022, Changes in Serum 25-Hydroxyvitamin D, Glucose and Lipid Metabolism, and Cardiac Function in Pregnant Women with Gestational Diabetes Mellitus Complicated by Subclinical Hypothyroidism and Their Clinical Significance. Hainan Medical Journal, 33(13): 1674–1677.
Li H, Ming Y, Meng X, 2023, Expression and Role of 25-(OH)D and Visfatin in Elderly Patients with Type 2 Diabetes Mellitus Complicated by Subclinical Hypothyroidism. China Practical Medicine, 18(5): 44–48.
Xu S, Feng X, Yao H, 2024, Efficacy of Levothyroxine Sodium Tablets in Treating Pregnant Women with Subclinical Hypothyroidism at Different Thyroid-Stimulating Hormone Levels. Northwestern Pharmaceutical Journal, 39(2): 221–225.
Yan L, Yang Z, Teng Y, et al., 2024, Changes in Serum TSH, Hcy, and 25(OH)D3 Levels and Their Clinical Significance in Pregnant Women with Hypothyroidism. Journal of Molecular Diagnostics and Therapy, 16(5): 881–884 + 889.
Liu M, Xiao L, Shi W, 2021, Clinical Efficacy and Effective Dose of L-T4 Replacement Therapy in Pregnant Women with Subclinical Hypothyroidism. China Medical Herald, 18(5): 80–83.
Qiao Y, Zhang H, Zhang J, 2025, Analysis of Pregnancy Outcomes and Their Influencing Factors in Pregnant Women with Hypothyroidism. Chinese Journal of Preventive Medicine, 27(6): 1038–1042.